Skip to main content
Log in

A novel evaluation system for whole-organ-engineered liver graft by ex vivo application to a highly reproducible hepatic failure rat model

  • Original Article
  • Tissue Engineering / Regenerative Medicine
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

In recent years, studies on liver graft construction using the decellularized liver as a template for transplantation therapy have attracted much attention. However, the therapeutic effect of constructed liver grafts in hepatic failure has not been evaluated. Therefore, we aimed to develop a novel evaluation system demonstrating the curative effect of a constructed liver graft in animals with hepatic failure. First, we developed a highly reproducible rat model of hepatic failure by combining 80% partial hepatectomy with warm ischemia. In this model, severity could be controlled by the warm ischemic period. We also constructed a liver graft by recellularization of decellularized liver, and confirmed the ammonia metabolic function in the graft in vitro as one of the most important functions for recovery from hepatic failure. The graft was then applied to our developed hepatic failure rat model using a blood extracorporeal circulation system. In this application, the graft metabolized the ammonia in the blood of animals with hepatic failure and was thus suggested to be effective for the treatment of hepatic failure. In summary, a novel evaluation system for whole-organ-engineered liver graft as a preliminary stage of transplantation was developed. This system was expected to provide much information about the curative effect of a constructed liver graft.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kim WR, et al. OPTN/SRTR 2016 annual data report: liver. Am J Transplant. 2018;18(suppl 1):172–253.

    Article  Google Scholar 

  2. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6.

    Article  CAS  Google Scholar 

  3. Ohashi K, et al. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med. 2007;13:880–5.

    Article  CAS  Google Scholar 

  4. Smith MK, et al. Delivery of hepatotrophic factors fails to enhance longer-term survival of subcutaneously transplanted hepatocytes. Tissue Eng. 2006;12(2):235–44.

    Article  CAS  Google Scholar 

  5. Chen AA, et al. Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci USA. 2011;108(29):11842–7.

    Article  CAS  Google Scholar 

  6. Rotem A, et al. Oxygen uptake rates in cultured rat hepatocytes. Biotechnol Bioeng. 1992;40(10):1286–91.

    Article  CAS  Google Scholar 

  7. Shirakigawa N, et al. Decellularized liver as a practical scaffold with a vascular network template for liver tissue engineering. J Biosci Bioeng. 2012;114(5):546–51.

    Article  CAS  Google Scholar 

  8. Shirakigawa N, et al. Base structure consisting of an endothelialized vascular-tree network and hepatocytes for whole liver engineering. J Biosci Bioeng. 2013;116(6):740–5.

    Article  CAS  Google Scholar 

  9. Uygun BE, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized matrix. Nat Med. 2010;16(7):814–20.

    Article  CAS  Google Scholar 

  10. Bao J, et al. Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant. 2011;20(5):753–66.

    Article  Google Scholar 

  11. Ko IK, et al. Bioengineered transplantable porcine livers with re-endothelialized vasculature. Biomaterials. 2015;40:72–9.

    Article  CAS  Google Scholar 

  12. Yagi H, et al. Human-scale whole-organ bioengineering for liver transplantation: a regenerative medicine approach. Cell Transplant. 2013;22(2):231–42.

    Article  Google Scholar 

  13. Meng F, et al. Whole liver engineering: a promising approach to develop functional liver surrogates. Liver Int. 2017;37(12):1759–72.

    Article  Google Scholar 

  14. Seglen PO. Preparation of isolated rat liver cells. In: Prescott DM, editor. Methods of cell biology. New York: Academic Press; 1976. p. 29–83.

    Google Scholar 

  15. Ijima H, Kawakami K. Promotion of monolayer formation and high expression of ammonia metabolism of primary rat hepatocytes on arginine-glycine-aspartic acid-containing peptide-coated polystyrene dish. J Biosci Bioeng. 2005;100(1):62–6.

    Article  CAS  Google Scholar 

  16. Bernal W, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46(6):1844–52.

    Article  CAS  Google Scholar 

  17. Suh KS, et al. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res. 1999;85(2):243–50.

    Article  CAS  Google Scholar 

  18. He Y, et al. A rat model for acute hepatic failure. Hepatobiliary Pancreat Dis Int. 2003;2(3):423–5.

    PubMed  Google Scholar 

  19. Tuñón MJ, et al. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol. 2009;15(25):3086–98.

    Article  Google Scholar 

  20. Eguchi S, et al. Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology. 1996;24(6):1452–9.

    Article  CAS  Google Scholar 

  21. Ijima H, et al. Evaluating the performance of a hybrid artificial liver support system with a recoverable hepatic failure rat model. Ann N Y Acad Sci. 2001;944:344–9.

    Article  CAS  Google Scholar 

  22. Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci. 1991;36(6):770–4.

    Article  CAS  Google Scholar 

  23. Newsome PN, et al. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl. 2000;6(1):21–31.

    CAS  PubMed  Google Scholar 

  24. Takagi M, et al. Analysis of the ammonium metabolism of rat primary hepatocytes and a human hepatocyte cell line Huh 7. Cytotechnology. 2000;32(1):9–15.

    Article  CAS  Google Scholar 

  25. Yamashita Y, et al. Efficacy of a larger version of the hybrid artificial liver support system using a polyurethane foam/spheroid packed-bed module in a warm ischemic liver failure pig model for preclinical experiments. Cell Transplant. 2003;12:101–7.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to Prof. Aishima from Saga University for helpful discussions and valuable insights on histological evaluation. We would also like to thank Editage (www.editage.jp) for English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroyuki Ijima.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 1242 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakamoto, H., Shirakigawa, N., Bual, R.P. et al. A novel evaluation system for whole-organ-engineered liver graft by ex vivo application to a highly reproducible hepatic failure rat model. J Artif Organs 22, 222–229 (2019). https://doi.org/10.1007/s10047-019-01106-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-019-01106-6

Keywords

Navigation